Edgewise Therapeutics, Inc. (EWTX)

Last Three Months

19-Feb-24 -- 18-May-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Other

Other

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

8

0

5

+1

0

+2

0

+3

Two Year Chart

19-May-22 -- 18-May-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
03-May-24 6:30 PM View:	02-May-24 Option Sale ($40.79K)	Carruthers R Michael Chief Financial Officer		Edgewise Therapeutics, Inc. - EWTX	9% 32.18K to 35.23K	0	0	--	--	Show Txns Hide Txns

03-May-24 6:29 PM View:	02-May-24 Option Sale ($32.49K)	Derakhshan Behrad Chief Business Officer		Edgewise Therapeutics, Inc. - EWTX	35% 9.93K to 13.42K	0	0	--	--	Show Txns Hide Txns

03-May-24 6:26 PM View:	02-May-24 Option Sale ($59.60K)	Koch Kevin President and CEO Director		Edgewise Therapeutics, Inc. - EWTX	2% 346.0K to 353.26K	0	0	--	--	Show Txns Hide Txns

03-May-24 6:31 PM View:	02-May-24 Option Sale ($36.99K)	Moore John R General Counsel		Edgewise Therapeutics, Inc. - EWTX	100% 0 to 3.25K	0	0	--	--	Show Txns Hide Txns

03-May-24 6:28 PM View:	02-May-24 Option Sale ($29.80K)	Russell Alan J Chief Scientific Officer Director		Edgewise Therapeutics, Inc. - EWTX	101% 3.61K to 7.24K	0	0	--	--	Show Txns Hide Txns

03-May-24 6:27 PM View:	02-May-24 Option Sale ($69.63K)	Donovan Joanne M. CMO		Edgewise Therapeutics, Inc. - EWTX	51% 13.16K to 19.9K	0	0	--	--	Show Txns Hide Txns